雙箭股份(002381.SZ)泰達宏利擬清倉減持不超6.23%的股份
格隆匯8月19日丨雙箭股份(002381.SZ)公佈,泰達宏利基金管理有限公司管理的泰達宏利價值成長定向增發202號資產管理計劃(泰達宏利價值成長定向增發202號資產管理計劃的證券賬户名稱為“泰達宏利基金-民生銀行-國民信託-國民信託·證通1號單一資金信託”(“泰達宏利”)),截至公告日持有公司無限售流通股2564.9301萬股,佔公司總股本比例6.23%。
泰達宏利,計劃在此次減持計劃公告之日起15個交易日後的6個月內通過集中競價交易及在此次減持計劃公告之日起3個交易日後的6個月內通過大宗交易、協議轉讓及其他合法合規方式合計減持所持雙箭股份不超過2564.9301萬股,佔公司總股本的6.23%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.